Daiwa Securities Group
JAZZ icon

Daiwa Securities Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Daiwa Securities Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
15,000
+6,417
+75% +$1.12M 0.01% 597
2025
Q4 		$1.46M Buy
8,583
+6,292
+275% +$965K ﹤0.01% 720
2025
Q3 		$302K Buy
2,291
+2,076
+966% +$249K ﹤0.01% 950
2025
Q2 		$23K Sell
215
-1,785
-89% -$194K ﹤0.01% 1094
2025
Q1 		$248K Buy
2,000
+1,800
+900% +$235K ﹤0.01% 912
2024
Q4 		$25K Sell
200
-37
-16% -$4.36K ﹤0.01% 1081
2024
Q3 		$26K Hold
237
– – ﹤0.01% 1093
2024
Q2 		$25K Sell
237
-5,349
-96% -$588K ﹤0.01% 1126
2024
Q1 		$673K Buy
5,586
+879
+19% +$108K ﹤0.01% 791
2023
Q4 		$579K Buy
4,707
+631
+15% +$78.7K ﹤0.01% 806
2023
Q3 		$528K Buy
4,076
+100
+3% +$13.3K ﹤0.01% 817
2023
Q2 		$493K Buy
3,976
+177
+5% +$23.8K ﹤0.01% 822
2023
Q1 		$556K Buy
3,799
+100
+3% +$14.8K ﹤0.01% 784
2022
Q4 		$589K Buy
3,699
+121
+3% +$17.7K ﹤0.01% 769
2022
Q3 		$477K Buy
3,578
+200
+6% +$30.4K ﹤0.01% 813
2022
Q2 		$527K Buy
3,378
+53
+2% +$8.16K ﹤0.01% 811
2022
Q1 		$518K Buy
3,325
+100
+3% +$14.5K ﹤0.01% 845
2021
Q4 		$411K Buy
3,225
+119
+4% +$15.6K ﹤0.01% 899
2021
Q3 		$404K Buy
3,106
+90
+3% +$13.6K ﹤0.01% 885
2021
Q2 		$536K Buy
3,016
+378
+14% +$65.5K ﹤0.01% 808
2021
Q1 		$434K Buy
2,638
+7
+0.3% +$1.15K ﹤0.01% 832
2020
Q4 		$434K Sell
2,631
-210
-7% -$31.3K ﹤0.01% 790
2020
Q3 		$405K Buy
2,841
+199
+8% +$24.7K ﹤0.01% 745
2020
Q2 		$32K Hold
2,642
– – ﹤0.01% 954
2020
Q1 		$264K Buy
2,642
+173
+7% +$22.4K ﹤0.01% 804
2019
Q4 		$360K Sell
2,469
-42
-2% -$5.71K ﹤0.01% 793
2019
Q3 		$322K Buy
2,511
+5
+0.2% +$670 ﹤0.01% 788
2019
Q2 		$357K Sell
2,506
-7
-0.3% -$941 ﹤0.01% 760
2019
Q1 		$359K Sell
2,513
-28
-1% -$3.65K ﹤0.01% 735
2018
Q4 		$315K Buy
2,541
+210
+9% +$31.2K ﹤0.01% 731
2018
Q3 		$392K Hold
2,331
– – ﹤0.01% 721
2018
Q2 		$402K Hold
2,331
– – ﹤0.01% 700
2018
Q1 		$352K Buy
2,331
+431
+23% +$63.2K ﹤0.01% 719
2017
Q4 		$256K Buy
1,900
+250
+15% +$34.7K ﹤0.01% 796
2017
Q3 		$241K Hold
1,650
– – ﹤0.01% 764
2017
Q2 		$257K Sell
1,650
-100
-6% -$15.3K ﹤0.01% 715
2017
Q1 		$254K Buy
1,750
+200
+13% +$26K ﹤0.01% 719
2016
Q4 		$169K Hold
1,550
– – ﹤0.01% 804
2016
Q3 		$188K Buy
1,550
+150
+11% +$20.2K ﹤0.01% 700
2016
Q2 		$198K Hold
1,400
– – ﹤0.01% 666
2016
Q1 		$183K Hold
1,400
– – ﹤0.01% 679
2015
Q4 		$197K Hold
1,400
– – ﹤0.01% 673
2015
Q3 		$186K Hold
1,400
– – ﹤0.01% 685
2015
Q2 		$246K Sell
1,400
-100
-7% -$18K ﹤0.01% 669
2015
Q1 		$259K Buy
1,500
+200
+15% +$34.3K ﹤0.01% 591
2014
Q4 		$213K Buy
+1,300
New +$216K ﹤0.01% 614

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Daiwa Securities Group's JAZZ Position: Q1 2026 in Review

Daiwa Securities Group increased its Jazz Pharmaceuticals (JAZZ) stake by 75% in Q1 2026, buying an estimated $1.12M and bringing the position to 15,000 shares worth $2.84M. The position accounts for 0.01% of the portfolio, ranked #597.

Daiwa Securities Group first reported a position in JAZZ in Q4 2014 and has held it in 46 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Daiwa Securities Group held 15,000 shares of Jazz Pharmaceuticals worth $2.84M as of Q1 2026.
  • Daiwa Securities Group bought 6,417 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.12M.
  • Jazz Pharmaceuticals made up 0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #597 holding.
  • Daiwa Securities Group first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 46 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.